Cangrelor for the treatment of patients with Arterial Thrombosis
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2018.1506767
Abstract: ABSTRACT Introduction: All oral P2Y12 receptor blockers are associated with some degree of delayed onset and offset of pharmacodynamic (PD) effects in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI). Although intravenous… read more here.
Keywords: treatment; treatment patients; cangrelor; patients arterial ... See more keywords